FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
2002 • 1,655 citations
The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
2002 • 1,478 citations
First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients
2002 • 272 citations
FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation
2004 • 216 citations
Pharmacodynamics of Single Doses of the Novel Immunosuppressant FTY720 in Stable Renal Transplant Patients
2003 • 102 citations
Single‐dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects
2004 • 80 citations
Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells
1999 • 70 citations
Pharmacokinetics and Cell Trafficking Dynamics of 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol Hydrochloride (FTY720) in Cynomolgus Monkeys after Single Oral and Intravenous Doses
2002 • 31 citations
Binding of a new vinca alkaloid derivative, S12363, to human plasma proteins and platelets. Usefulness of an erythrocyte partitioning technique
1992 • 12 citations
ROLE OF CYP4F IN THE METABOLIC CLEARANCE OF FTY720 - PREDICTION OF LOW DRUG TO DRUG INTERACTION POTENTIAL.
2000 • 10 citations
Cited By (0)
No citing papers found in database